Position in ABBV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,164,956,491
-$32,547,638 QoQ
Shares Held
46,737,581
+4.7% QoQ
Ownership
2.65%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.92614080733019.ToString("F0")%
Shared 0.ToString("F0")%
None 0.0738591926698132.ToString("F0")%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $67,874,952,284 across 14 Drug Manufacturers - General names. ABBV ranks #3 (15.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,191,864 | $18,571,870,750 | |
| 2 | JNJ |
Johnson & Johnson
|
59,164,862 | $14,462,258,866 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
46,737,581 | $10,164,956,491 | |
| 4 | MRK |
Merck & Co., Inc.
|
59,558,154 | $7,164,250,343 | |
| 5 | AMGN |
Amgen Inc
|
15,430,524 | $5,429,229,869 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
29,726,052 | $4,142,919,866 | |
| 7 | PFE |
Pfizer Inc
|
133,561,742 | $3,750,413,715 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
55,286,174 | $3,353,106,452 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,164,956,491 | 46,737,581 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $10,197,504,129 | 44,629,980 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $9,363,360,208 | 40,439,493 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $7,272,285,512 | 39,178,351 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $8,014,892,176 | 38,253,590 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $6,600,654,593 | 37,144,933 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $7,141,083,166 | 36,161,045 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $6,291,653,759 | 36,681,750 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $6,827,776,311 | 37,494,653 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $5,736,599,805 | 37,017,486 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $5,397,041,058 | 36,207,172 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,709,209,336 | 34,952,938 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $5,425,754,996 | 34,045,021 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,454,742,979 | 33,752,509 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,540,391,539 | 33,830,501 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,607,271,359 | 30,081,427 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,655,839,889 | 28,720,251 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,861,465,288 | 28,518,946 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,994,535,059 | 27,760,592 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $3,068,871,055 | 27,244,949 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,947,111,863 | 27,232,599 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $2,858,968,049 | 26,681,923 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $2,289,170,956 | 26,135,072 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,843,154,562 | 28,958,592 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,963,683,345 | 25,773,505 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||